Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 14 Mar 23 EFFECT Notice of effectiveness
- 9 Mar 23 POS AM Prospectus update (post-effective amendment)
- 24 Aug 21 EFFECT Notice of effectiveness
-
13 Aug 21 S-3 Shelf registration
FSTX similar filings
Filing view
External links
Exhibit 23.2
We consent to the incorporation by reference in this Registration Statement on Form S-3 of F-star Therapeutics, Inc. of our report dated February 14, 2020, relating to the consolidated financial statements of Spring Bank Pharmaceuticals, Inc. and subsidiaries, appearing in the Annual Report on Form 10-K of Spring Bank Pharmaceuticals, Inc. for the year ended December 31, 2019.
We also consent to the reference to our firm under the heading “Experts” in such prospectus.
/s/ RSM US LLP
Boston, Massachusetts
August 13, 2021